Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 4:35 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 524790 | NSE: EVERESTO

Everest Organics Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹49.89Overvalued by 77.43%vs CMP ₹221.00

P/E (36.7) × ROE (2.2%) × BV (₹74.70) × DY (2.00%)

₹113.46Overvalued by 48.66%vs CMP ₹221.00
MoS: -94.8% (Negative)Confidence: 63/100 (Moderate)Models: 1 Under, 8 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹66.5724%Over (-69.9%)
Graham NumberEarnings₹100.5114%Over (-54.5%)
DCFCash Flow₹100.9512%Over (-54.3%)
Net Asset ValueAssets₹75.048%Over (-66%)
EV/EBITDAEnterprise₹83.2610%Over (-62.3%)
Dividend DiscountDividends₹82.5010%Over (-62.7%)
Earnings YieldEarnings₹60.108%Over (-72.8%)
ROCE CapitalReturns₹369.7310%Under (+67.3%)
Revenue MultipleRevenue₹163.446%Over (-26%)
Consensus (9 models)₹113.46100%Overvalued
Key Drivers: EPS CAGR 33.4% lifts DCF — verify sustainability. | ROE 2.2% is below cost of equity.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 33.4%

*Investments are subject to market risks

Investment Snapshot

50
Everest Organics Ltd scores 50/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health38/100 · Weak
ROCE 1.8% WeakROE 2.2% WeakD/E 0.42 ModerateInterest Coverage 0.0x RiskyProfitable 2/5 years Inconsistent
Smart Money50/100 · Moderate
Promoter holding at 59.6% Stable
Earnings Quality65/100 · Strong
OPM expanding (2% → 6%) Improving
Quarterly Momentum60/100 · Moderate
Revenue (4Q): +10% YoY Growing
Industry Rank35/100 · Weak
P/E 36.7 vs industry 53.8 Cheaper than peersROCE 1.8% vs industry 16.4% Below peersROE 2.2% vs industry 15.2% Below peers3Y sales CAGR: -7% Shrinking

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 4:35 am

Market Cap 215 Cr.
Current Price 221
Intrinsic Value₹113.46
High / Low 536/197
Stock P/E36.7
Book Value 74.7
Dividend Yield0.00 %
ROCE1.76 %
ROE2.23 %
Face Value 10.0
PEG Ratio1.10

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Everest Organics Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Everest Organics Ltd 215 Cr. 221 536/19736.7 74.70.00 %1.76 %2.23 % 10.0
BDH Industries Ltd 219 Cr. 381 524/24121.0 1231.18 %17.8 %14.2 % 10.0
Gennex Laboratories Ltd 208 Cr. 8.55 17.2/7.0511.9 8.790.00 %13.0 %10.2 % 1.00
Ambalal Sarabhai Enterprises Ltd 203 Cr. 26.5 42.0/23.111.4 19.20.00 %9.12 %6.25 % 10.0
Nectar Lifescience Ltd 190 Cr. 9.76 28.3/9.20 32.00.00 %5.36 %11.2 % 1.00
Industry Average19,815.15 Cr1,053.8453.84201.200.39%16.35%15.16%6.10

All Competitor Stocks of Everest Organics Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 43.2950.7542.6749.4552.5152.6232.4544.0542.0540.9353.8151.0042.59
Expenses 45.7948.4740.1546.7449.7149.6736.1140.6238.0337.4949.3745.8739.05
Operating Profit -2.502.282.522.712.802.95-3.663.434.023.444.445.133.54
OPM % -5.78%4.49%5.91%5.48%5.33%5.61%-11.28%7.79%9.56%8.40%8.25%10.06%8.31%
Other Income 5.650.690.220.240.130.300.330.140.000.220.550.290.25
Interest 0.810.951.291.491.451.241.291.351.401.151.311.231.23
Depreciation 1.101.261.291.321.331.851.471.471.471.561.521.521.52
Profit before tax 1.240.760.160.140.150.16-6.090.751.150.952.162.671.04
Tax % -21.77%85.53%75.00%78.57%93.33%62.50%0.00%1.33%0.87%-206.32%35.19%56.93%65.38%
Net Profit 1.520.110.040.030.020.06-6.090.741.142.911.411.160.36
EPS in Rs 1.900.140.050.040.020.08-7.610.921.423.001.451.190.37

Last Updated: March 3, 2026, 9:58 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 27, 2026, 5:00 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 9610699107112156167182200183197159188
Expenses 919894101105138148159194182186152172
Operating Profit 586671819236111717
OPM % 6%7%6%6%6%11%11%13%3%1%6%5%9%
Other Income 1-0-01111127111
Interest 3333333333555
Depreciation 2332333344666
Profit before tax 12022121417201-37
Tax % 21%20%18%24%28%39%23%21%34%311%77%-60%
Net Profit 12012811141-00-16
EPS in Rs 0.541.692.149.3913.6217.151.42-0.220.18-1.336.01
Dividend Payout % 0%0%0%0%0%11%7%9%0%0%0%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162017-20182018-20192019-20202020-20212021-20222022-2023
YoY Net Profit Growth (%)100.00%-100.00%100.00%300.00%37.50%27.27%-92.86%-100.00%
Change in YoY Net Profit Growth (%)0.00%-200.00%200.00%200.00%-262.50%-10.23%-120.13%-7.14%

Everest Organics Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2014-2015 to 2022-2023.

Growth

Compounded Sales Growth
10 Years:4%
5 Years:-1%
3 Years:-7%
TTM:-3%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:%
TTM:204%
Stock Price CAGR
10 Years:%
5 Years:7%
3 Years:44%
1 Year:182%
Return on Equity
10 Years:11%
5 Years:6%
3 Years:-1%
Last Year:-2%

Last Updated: September 5, 2025, 3:26 pm

Balance Sheet

Last Updated: March 3, 2026, 12:58 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 993888888881010
Reserves -5-338111826393938386063
Borrowings 26242819222118233951584849
Other Liabilities 353742515460686692105123107115
Total Liabilities 6567768694107120135178202227224237
Fixed Assets 24242733343839444954525049
CWIP 00111010812212322
Investments 0000000000000
Other Assets 4142475260688092121136153152166
Total Assets 6567768694107120135178202227224237

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 14710591014141816-5
Cash from Investing Activity + -3-3-7-8-4-5-6-12-17-16-13-5
Cash from Financing Activity + 2-2-0-2-1-3-3-22-3-316
Net Cash Flow 0-000-010-0-1006
Free Cash Flow -21021237-353-11
CFO/OP 21%52%119%162%64%50%51%59%214%1,981%149%-76%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-21.00-16.00-22.00-13.00-15.00-3.001.000.00-33.00-50.00-47.00-41.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 1061001171051249597102125152185202
Inventory Days 464455737271102110110139128166
Days Payable 184184235260251190211183212282324351
Cash Conversion Cycle -32-40-63-83-55-24-1229249-1117
Working Capital Days -43-30-38-50-34-157219-12-213
ROCE %13%19%11%13%13%35%35%34%6%4%6%2%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 74.15%74.15%74.15%74.15%74.15%74.15%74.15%74.15%61.09%60.99%59.64%59.61%
DIIs 0.03%0.03%0.03%0.03%0.03%0.03%0.05%0.05%0.02%0.02%0.02%0.02%
Public 25.83%25.83%25.82%25.82%25.83%25.83%25.81%25.80%38.90%38.99%40.35%40.36%
No. of Shareholders 10,83410,63410,49410,24210,0239,7929,9969,3268,7568,2818,0797,804

Shareholding Pattern Chart

No. of Shareholders

Everest Organics Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) -2.970.17-0.231.4317.14
Diluted EPS (Rs.) -2.970.17-0.231.4317.14
Cash EPS (Rs.) 4.817.425.366.1721.36
Book Value[Excl.RevalReserv]/Share (Rs.) 72.0357.3057.7758.5058.22
Book Value[Incl.RevalReserv]/Share (Rs.) 72.0357.3057.7758.5058.22
Dividend / Share (Rs.) 0.000.000.000.501.50
Revenue From Operations / Share (Rs.) 164.23246.55228.81250.06226.96
PBDIT / Share (Rs.) 8.1414.849.8410.8029.88
PBIT / Share (Rs.) 2.007.604.256.0525.66
PBT / Share (Rs.) -3.340.760.112.1721.59
Net Profit / Share (Rs.) -1.330.17-0.221.4317.14
PBDIT Margin (%) 4.956.014.304.3113.16
PBIT Margin (%) 1.223.081.852.4211.30
PBT Margin (%) -2.030.300.040.869.51
Net Profit Margin (%) -0.800.07-0.090.577.55
Return on Networth / Equity (%) -1.840.30-0.392.4429.44
Return on Capital Employeed (%) 2.309.125.287.3935.38
Return On Assets (%) -0.570.06-0.090.6410.13
Long Term Debt / Equity (X) 0.130.310.250.230.12
Total Debt / Equity (X) 0.681.261.100.820.42
Asset Turnover Ratio (%) 0.700.920.961.281.42
Current Ratio (X) 1.060.930.961.051.15
Quick Ratio (X) 0.730.660.620.670.72
Inventory Turnover Ratio (X) 3.582.732.833.773.85
Dividend Payout Ratio (NP) (%) 0.000.00-219.5369.948.74
Dividend Payout Ratio (CP) (%) 0.000.009.3216.197.02
Earning Retention Ratio (%) 0.000.00319.5330.0691.26
Cash Earning Retention Ratio (%) 0.000.0090.6883.8192.98
Interest Coverage Ratio (X) 1.522.172.382.787.34
Interest Coverage Ratio (Post Tax) (X) 0.751.030.941.375.21
Enterprise Value (Cr.) 285.94148.80126.35177.17202.22
EV / Net Operating Revenue (X) 1.790.750.690.881.11
EV / EBITDA (X) 36.1512.5316.0520.518.46
MarketCap / Net Operating Revenue (X) 1.530.460.410.691.01
Retention Ratios (%) 0.000.00319.5330.0591.25
Price / BV (X) 3.502.001.652.973.95
Price / Net Operating Revenue (X) 1.530.460.410.691.01
EarningsYield -0.010.000.000.010.07

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Everest Organics Ltd. is a Public Limited Listed company incorporated on 19/02/1993 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24230TG1993PLC015426 and registration number is 015426. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 159.48 Cr. and Equity Capital is Rs. 9.71 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
PharmaceuticalsAroor Village, Sadasivpet Mandal, Sangareddy Dist. Telangana 502291Contact not found
Management
NamePosition Held
Mr. Prasad Venkata Satya Sundara SrikakolapuChairman & Ind.Director
Dr. Sri Kakarlapudi SirishaManaging Director
Mr. Srikakarlapudi HarikrishnaWhole Time Director
Mr. Kirankumar RampallyNon Exe.Non Ind.Director
Mr. Venkata Satyanarayana Murthy VadaliIndependent Director

FAQ

What is the intrinsic value of Everest Organics Ltd and is it undervalued?

As of 10 April 2026, Everest Organics Ltd's intrinsic value is ₹113.46, which is 48.66% lower than the current market price of ₹221.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (2.23 %), book value (₹74.7), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Everest Organics Ltd?

Everest Organics Ltd is trading at ₹221.00 as of 10 April 2026, with a FY2026-2027 high of ₹536 and low of ₹197. The stock is currently near its 52-week low. Market cap stands at ₹215 Cr..

How does Everest Organics Ltd's P/E ratio compare to its industry?

Everest Organics Ltd has a P/E ratio of 36.7, which is below the industry average of 53.84. This is broadly in line with or below the industry average.

Is Everest Organics Ltd financially healthy?

Key indicators for Everest Organics Ltd: ROCE of 1.76 % is on the lower side compared to the industry average of 16.35%; ROE of 2.23 % is below ideal levels (industry average: 15.16%). Dividend yield is 0.00 %.

Is Everest Organics Ltd profitable and how is the profit trend?

Everest Organics Ltd reported a net profit of ₹-1 Cr in Mar 2025 on revenue of ₹159 Cr. Compared to ₹1 Cr in Mar 2022, the net profit shows a declining trend.

Does Everest Organics Ltd pay dividends?

Everest Organics Ltd has a dividend yield of 0.00 % at the current price of ₹221.00. The company is currently not paying meaningful dividends.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Everest Organics Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports